Surprisingly, this investigation revealed that the level of METTL3, METTL14, WTAP, ALKBH5, together with FTO did not show any notable variation when comparing control CRC cells to DDP-resistant cells (Fig. 4E). This evidence concerns the gene METTL3 and colorectal carcinoma.